• Further study is needed into neonatal screening
    Scientists call for further analysis into costs and benefits of greater newborn screening

Electrophoretic Separations

Further study is needed into neonatal screening

Jun 22 2011

Scientists have called for further investigation into the costs and benefits of extending national newborn screening programmes.

For a study, published in Orphanet Journal of Rare Diseases, the scientists used analytical chemistry methods to determine the efficacy and outcomes of expanded newborn screening for metabolic diseases.

The team used data collected from observational study over ten years, from January 1st 1999 to June 30th 2009, and found 373 cases with confirmed diagnosis of a metabolic disorder from a total group of 1,084,195 neonates.

Scientists discovered that early diagnosis provided the optimal outcome for children with metabolic disorders, particularly those with medium-chain acyl-CoA dehydrogenase deficiency.

However, they found that later decompensation may not be completely prevented despite pre-symptomatic treatment.

"Metabolic decompensation does not necessarily result in impairment of intellectual development, but there is a definite association between the two," the scientists noted.

In conclusion of the study, the team suggested that much more investigation is needed into more intensive national newborn screening to discover the likely benefits, harms and costs in different populations.

Digital Edition

Chromatography Today - Buyers' Guide 2022

October 2023

In This Edition Modern & Practical Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...

View all digital editions


EuCheMS Chemistry Congress

Jul 07 2024 Dublin, Ireland

HPLC 2024

Jul 20 2024 Denver, CO, USA

ICMGP 2024

Jul 21 2024 Cape Town, South Africa

ACS National Meeting - Fall 2024

Aug 18 2024 Denver, CO, USA

View all events